Cite
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States
MLA
Martin, Steinau, et al. “Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States.” Emerging Infectious Diseases, vol. 20, no. 5, Apr. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d3cc7aab973e0849ddd56cfbd86638a0&authtype=sso&custid=ns315887.
APA
Martin, S., Mona, S., Marc T, G., Edward S, P., Meg, W., Jennifer L, C., Charles F, L., Edward J, W., Brenda Y, H., Glen, C., Maria S, S., Claudia, H., Youjie, H., Wendy, C., Christopher, L., Elizabeth R, U., & Andre, K. (2014). Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerging Infectious Diseases, 20(5).
Chicago
Martin, Steinau, Saraiya Mona, Goodman Marc T, Peters Edward S, Watson Meg, Cleveland Jennifer L, Lynch Charles F, et al. 2014. “Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States.” Emerging Infectious Diseases 20 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d3cc7aab973e0849ddd56cfbd86638a0&authtype=sso&custid=ns315887.